Gatta L - Search Results

1

Helicobacter pylori culture: from bench to bedside.

Zullo A, Francesco V, Gatta L. Zullo A, et al. Among authors: gatta l. Ann Gastroenterol. 2022 May-Jun;35(3):243-248. doi: 10.20524/aog.2022.0703. Epub 2022 Mar 25. Ann Gastroenterol. 2022. PMID: 35599931 Free PMC article. Review.

2

High eradication rates of Helicobacter pylori with a new sequential treatment.

Zullo A, Vaira D, Vakil N, Hassan C, Gatta L, Ricci C, De Francesco V, Menegatti M, Tampieri A, Perna F, Rinaldi V, Perri F, Papadìa C, Fornari F, Pilati S, Mete LS, Merla A, Potì R, Marinone G, Savioli A, Campo SM, Faleo D, Ierardi E, Miglioli M, Morini S. Zullo A, et al. Among authors: gatta l. Aliment Pharmacol Ther. 2003 Mar 1;17(5):719-26. doi: 10.1046/j.1365-2036.2003.01461.x. Aliment Pharmacol Ther. 2003. PMID: 12641522 Free article. Clinical Trial.

3

Susceptibility of Helicobacter pylori to metronidazole.

Perna F, Gatta L, Figura N, Ricci C, Tampieri A, Holton J, Miglioli M, Vaira D. Perna F, et al. Among authors: gatta l. Am J Gastroenterol. 2003 Oct;98(10):2157-61. doi: 10.1111/j.1572-0241.2003.07681.x. Am J Gastroenterol. 2003. PMID: 14572561

4

Sequential therapy for H. pylori: an 'aberrant' therapy ready for general use.

Zullo A, Hassan C, Morini S, De Francesco V, Ierardi E, Panella C, Gatta L, Vaira D. Zullo A, et al. Among authors: gatta l. Dig Liver Dis. 2004 Dec;36(12):852-3; author reply 853. doi: 10.1016/j.dld.2004.08.005. Dig Liver Dis. 2004. PMID: 15646435 No abstract available.

5

High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study.

Zullo A, Gatta L, De Francesco V, Hassan C, Ricci C, Bernabucci V, Cavina M, Ierardi E, Morini S, Vaira D. Zullo A, et al. Among authors: gatta l. Aliment Pharmacol Ther. 2005 Jun 15;21(12):1419-24. doi: 10.1111/j.1365-2036.2005.02519.x. Aliment Pharmacol Ther. 2005. PMID: 15948808 Free article. Clinical Trial.

6

A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.

Gatta L, Zullo A, Perna F, Ricci C, De Francesco V, Tampieri A, Bernabucci V, Cavina M, Hassan C, Ierardi E, Morini S, Vaira D. Gatta L, et al. Aliment Pharmacol Ther. 2005 Jul 1;22(1):45-9. doi: 10.1111/j.1365-2036.2005.02522.x. Aliment Pharmacol Ther. 2005. PMID: 15963079 Free article.

7

Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial.

Vaira D, Zullo A, Vakil N, Gatta L, Ricci C, Perna F, Hassan C, Bernabucci V, Tampieri A, Morini S. Vaira D, et al. Among authors: gatta l. Ann Intern Med. 2007 Apr 17;146(8):556-63. doi: 10.7326/0003-4819-146-8-200704170-00006. Ann Intern Med. 2007. PMID: 17438314 Clinical Trial.

8

Errors in a meta-analysis of treatments for Helicobacter pylori infection.

Gatta L, Di Mario F, Zullo A, Vaira D. Gatta L, et al. Ann Intern Med. 2008 Nov 4;149(9):686; author reply 686. doi: 10.7326/0003-4819-149-9-200811040-00014. Ann Intern Med. 2008. PMID: 18981492 No abstract available.

9

Newer agents for Helicobacter pylori eradication.

Fiorini G, Zullo A, Gatta L, Castelli V, Ricci C, Cassol F, Vaira D. Fiorini G, et al. Among authors: gatta l. Clin Exp Gastroenterol. 2012;5:109-12. doi: 10.2147/CEG.S25422. Epub 2012 Jun 18. Clin Exp Gastroenterol. 2012. PMID: 22767998 Free PMC article.

10

High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy.

Saracino IM, Zullo A, Holton J, Castelli V, Fiorini G, Zaccaro C, Ridola L, Ricci C, Gatta L, Vaira D. Saracino IM, et al. Among authors: gatta l. J Gastrointestin Liver Dis. 2012 Dec;21(4):363-5. J Gastrointestin Liver Dis. 2012. PMID: 23256118 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

238 results

Search Page